Findings from African-American MS patients seem to support the idea that DRB1* is the primary driver of the association [35], but other data indicate that both DRB1 and DQB1 molecules are fundamental players in determining individuals' MS risk [19]. Here, HLA-DRB1 is linked to myeloid sarcoma.